Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Pharmaxis Ltd ( (AU:SNT) ).
Pharmaxis Ltd has released a quarterly update, highlighting its strategic focus on the development and commercialization of its product pipeline. The announcement underscores the potential impact of these developments on the company’s operational and market positioning, though it acknowledges the inherent risks and uncertainties involved in achieving these goals.
The most recent analyst rating on (AU:SNT) stock is a Buy with a A$0.12 price target. To see the full list of analyst forecasts on Pharmaxis Ltd stock, see the AU:SNT Stock Forecast page.
More about Pharmaxis Ltd
Average Trading Volume: 9,771,429
Technical Sentiment Signal: Sell
Current Market Cap: A$97.56M
For an in-depth examination of SNT stock, go to TipRanks’ Overview page.